Explanatory Note
This Amendment No. 4 to the statement on beneficial ownership on Schedule 13D (this Amendment
No. 4) amends and supplements the information set forth in the Statement on Schedule 13D filed by the Reporting Persons with the SEC on July 15, 2022, as amended by Amendment No. 1 thereto filed by the
Reporting Person with the SEC on September 15, 2022, Amendment No. 2 thereto filed by the Reporting Person with the SEC on September 10, 2024 and Amendment No. 3 thereto filed by the Reporting Person with the SEC on
September 16, 2024 (collectively, the Original Schedule 13D). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Original Schedule 13D. Except as
specifically provided herein, this Amendment No. 4 does not modify any of the information previously reported in the Original Schedule 13D.
Item 4. |
Purpose of the Transaction |
Item 4 of the Original Schedule 13D is hereby amended and supplemented as by adding the following immediately prior to last paragraph thereof:
On November 12, 2024, in connection with a registered secondary public offering (the November 2024 Secondary Offering) of
Common Stock of the Issuer, Vertex Holdco entered into an underwriting agreement (the November 2024 Underwriting Agreement) with the Issuer, Robert W. Baird & Co. Incorporated, Goldman Sachs & Co. LLC and Morgan
Stanley & Co. LLC, as representatives of the several underwriters listed on Schedule II thereto (the November 2024 Underwriters). Pursuant to the November 2024 Underwriting Agreement, Vertex Holdco agreed to sell to the November
2024 Underwriters, and the November 2024 Underwriters agreed to purchase from Vertex Holdco, subject to and upon the terms and conditions set forth therein, 2,500,000 shares of Common Stock at a price of $58.1025 per share. In addition, pursuant to
the November 2024 Underwriting Agreement, the November 2024 Underwriters have a 30-day option to purchase up to an additional 375,000 shares of Common Stock on the same terms. The sale of the 2,500,000 shares
in the November 2024 Secondary Offering closed on November 14, 2024.
In connection with the November 2024 Secondary Offering, Vertex
Holdco entered into a lock-up agreement (the November 2024 Lock-up Agreement) with the November 2024 Underwriters. Under the November 2024 Lock-up Agreement, Vertex Holdco agreed, subject to certain exceptions, not to offer, sell, contract to sell, pledge or otherwise dispose of any shares of Common Stock for 60 days after November 12, 2024.
The foregoing descriptions of the November 2024 Underwriting Agreement and November 2024 Lock-up
Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the November 2024 Underwriting Agreement, which includes the form of the November 2024 Lock-up
Agreement as an exhibit, and which is filed as Exhibit 99.8 hereto.
Item 5. |
Interest in Securities of the Issuer |
Paragraphs (a), (b) and (c) of Item 5 of the Original Schedule 13D is hereby amended and restated in its entirety to read
as follows:
(a) and (b) The responses of the Reporting Persons to Rows (7) through (11), and (13) of the cover pages
of this Amendment No. 4 are incorporated herein by reference. The Reporting Persons may be deemed to beneficially own an aggregate of 14,167,286 shares of Common Stock. This amount consists of: (i) 13,700,001 shares of Common Stock held
directly by Vertex Holdco and indirectly by AIP Fund VI and Vertex Funding; (ii) 375,420 shares of Common Stock held directly by Lightship; and (iii) 91,865 shares of Common Stock over which Vertex Holdco holds an irrevocable proxy that entitles it
to vote the shares with respect to certain matters (described further in Item 6 of the Original Schedule 13D, under the header Shareholders Agreement). In its capacity as the general partner of each of AIP Fund VI and Credit
Opportunity Fund, AIP GP may be deemed to indirectly beneficially own all 14,167,286 shares of Common Stock reported herein. The aggregate percentage of shares of Common Stock reported as beneficially owned by the Reporting Persons was calculated
based on 31,560,490 shares of Common Stock issued and outstanding as of November 8, 2024, as disclosed in the Issuers preliminary prospectus supplement filed with the SEC on November 14, 2024 pursuant to Rule 424(b)(5) under the
Securities Act of 1933, as amended.